Founded | 1971 |
|---|---|
Led by | Benjamin Yerxa |
HQ in | Columbia, MD |
Effectiveness & Efficiency 
What is the impact? | 20 genes linked to retinal disease identified and over 26 clinical trials for potential treatments launched in 2017-19, with over $15 million dedicated to fund 80 grants in 2019 |
|---|---|
Growth in last 3 years? | % Unknown in clients served |
How is money spent? | $33,924,028 spent last fiscal year to serve 142,150 website visitors, not including millions helped worldwide through research funded |
Is fundraising efficient? | 14¢ spent to raise $1 from 39,571 donors |
Leadership & Focus
Team | 50 staff + 2,500 volunteers + board of 20 |
|---|---|
Mission | To drive the research that will provide preventions, treatments and cures for people affected by retinitis pigmentosa, age-related macular degeneration, Usher syndrome and the entire spectrum of retinal degenerative diseases |
Topic(s) | Disabilities, Medical Research |
People Served | People with Disabilities |
Location(s) | 7 (view list) |
Not a Member Yet?
- View Sample Nonprofit Analytics to see all 175 fields about strategy, finances, leadership, and impact that members can access.
- Members can purchase Evaluations. Excellence in Giving uses the most recent Analytics to assess the strengths & weaknesses of a nonprofit’s strategy, leadership, finances, and impact in a 1-page report (completed in 10 business days if not instantly available).